Skip to main content

Deals

Maxim Partners invests in KGK Science

Saturday, August 8, 2026 · first reported by Private Capital Journal

Maxim Partners led a growth investment in KGK Science, a North American contract research organization specializing in clinical trials; closed June 30, 2026, financial terms undisclosed.

Also named
KGK Science Inc.
Asset class
Private equity
Geography
North America

The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.

See an error?

More in Deals

From the same day

Got news? Send it to us →